Found 34 matching trials
An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris
PHASE1This study will assess the safety, tolerability, and efficacy of dapsone in...
Location
Multiple Locations
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
PHASE1This study will evaluate the potential of dapsone gel and its vehicle to ca...
Location
Multiple Locations
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
PHASE4A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used...
Location
Multiple Locations
Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris
PHASE4The goal of this randomized, triple-blind, vehicle-controlled clinical tria...
Location
Istanbul Training and Research Hospital
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris
PHASE4This study will evaluate the effect of dapsone gel in female subjects with ...
Location
Multiple Locations
Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
PHASE1This study will investigate the pharmacokinetics, safety and tolerability o...
Location
Multiple Locations
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
PHASE1This study will evaluate the potential of dapsone gel and its vehicle to ca...
Location
Multiple Locations
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
PHASE3To evaluate the therapeutic effect of Dapsone and Placebo gel in the treatm...
Location
Unison Center for Clinical Trials
Effect of New Topical Preparation for Treatment of Acne Vulgaris
PHASE2The investigators propose a randomized, double-blind control trial study to...
Location
Amgad El-Sayed Salem
A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash
PHASE2The purpose of this study is to evaluate the safety and preliminary efficac...
Location
Northwestern University Robert H. Lurie Comprehensive Cancer Center